Levacetylleucine for the treatment of neurological manifestations of Niemann-Pick disease type C

Michael Strupp, Grant C Churchill, Antony Galione, Frances M Platt

Open source

DOI
10.1080/14656566.2026.2760630
Published
2026-11-09
Container
Expert Opinion on Pharmacotherapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14656566.2026.2760630,
  title = {Levacetylleucine for the treatment of neurological manifestations of Niemann-Pick disease type C},
  author = {Michael Strupp and Grant C Churchill and Antony Galione and Frances M Platt},
  year = {2026},
  journal = {Expert Opinion on Pharmacotherapy},
  doi = {10.1080/14656566.2026.2760630},
  url = {https://doi.org/10.1080/14656566.2026.2760630}
}

RIS

TY  - JOUR
TI  - Levacetylleucine for the treatment of neurological manifestations of Niemann-Pick disease type C
AU  - Michael Strupp
AU  - Grant C Churchill
AU  - Antony Galione
AU  - Frances M Platt
PY  - 2026
JO  - Expert Opinion on Pharmacotherapy
DO  - 10.1080/14656566.2026.2760630
UR  - https://doi.org/10.1080/14656566.2026.2760630
ER  - 

APA

Strupp, M., Churchill, G. C., Galione, A., & Platt, F. M. (2026). Levacetylleucine for the treatment of neurological manifestations of Niemann-Pick disease type C. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2026.2760630

Source records